ProShare Advisors LLC - CELLDEX THERAPEUTICS INC NEW ownership

CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 84 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q4 2018. The put-call ratio across all filers is - and the average weighting 1.2%.

Quarter-by-quarter ownership
ProShare Advisors LLC ownership history of CELLDEX THERAPEUTICS INC NEW
ValueSharesWeighting
Q3 2018$30,0000.0%66,244
+9.9%
0.00%
Q2 2018$30,000
-83.9%
60,261
-24.4%
0.00%
-100.0%
Q1 2018$186,000
-29.5%
79,689
-14.1%
0.00%
-50.0%
Q4 2017$264,000
+14.3%
92,790
+15.1%
0.00%0.0%
Q3 2017$231,000
+24.9%
80,606
+7.6%
0.00%0.0%
Q2 2017$185,000
-32.7%
74,909
-1.8%
0.00%
-33.3%
Q1 2017$275,000
-5.5%
76,264
-7.3%
0.00%0.0%
Q4 2016$291,000
-1.0%
82,240
+13.0%
0.00%
-25.0%
Q3 2016$294,000
-21.4%
72,759
-14.6%
0.00%
-20.0%
Q2 2016$374,000
+16.1%
85,177
+0.1%
0.01%
+25.0%
Q1 2016$322,000
-78.1%
85,117
-9.1%
0.00%
-77.8%
Q4 2015$1,469,000
+64.7%
93,666
+10.7%
0.02%
+38.5%
Q3 2015$892,000
-61.2%
84,594
-7.2%
0.01%
-59.4%
Q2 2015$2,298,000
-13.5%
91,116
-4.4%
0.03%
+3.2%
Q1 2015$2,656,000
+85.5%
95,298
+21.4%
0.03%
+82.4%
Q4 2014$1,432,000
+35.6%
78,487
-3.7%
0.02%
+21.4%
Q3 2014$1,056,000
-33.8%
81,520
-16.6%
0.01%
-33.3%
Q2 2014$1,595,000
-43.1%
97,747
-38.3%
0.02%
-40.0%
Q1 2014$2,801,000
+173.8%
158,522
+275.1%
0.04%
+133.3%
Q4 2013$1,023,000
-63.7%
42,261
-46.9%
0.02%
-77.6%
Q3 2013$2,818,000
+165.8%
79,548
+17.2%
0.07%
+219.0%
Q2 2013$1,060,00067,8790.02%
Other shareholders
CELLDEX THERAPEUTICS INC NEW shareholders Q4 2018
NameSharesValueWeighting ↓
KLP Enterprises, LLC 6,865,006$24,302,000100.00%
TSP Capital Management Group, LLC 886,398$3,138,0001.60%
Marcus Capital, LLC 109,950$389,0000.42%
RTW INVESTMENTS, LP 239,662$848,0000.32%
COLUMBIA WANGER ASSET MANAGEMENT LLC 6,195,855$21,933,0000.31%
Benchmark Capital Advisors 66,800$236,0000.20%
Bellevue Group AG 160,000$566,0000.12%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 632,944$2,241,0000.09%
PDT Partners, LLC 369,300$1,307,0000.09%
Vident Investment Advisory, LLC 196,715$696,0000.08%
View complete list of CELLDEX THERAPEUTICS INC NEW shareholders